|
1 Burton GJ，Jauniaux E. Placental oxidative stress：Frommiscarriage to preeclampsia. J Soc Gynecol Investing，2004，11 (6)：342-352.
|
|
2 Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenicfactors and the risk of preeclampsia. N Engl J Med，2004，350:672-676.
|
|
3 Bdolah Y，Sukhatme VP，Karumanchi SA. Angiogenic imbalance in the pathophysiology of preeclampsia：Newer insights. Semin Nephrol, 2004,7 (3)：548-556.
|
|
4 Maynard SE，Min JY，Merchan J，et al. Excess placental soluble fms-like tyrosine kinase 1 (sFltl) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. Clin Invest，2003,111：600-602.
|
|
5 Chakraborty C，Gleeson LM，Mckinnon T，et al. Regulation of human trophoblast migyation and invasiveness. Can J Physiol Pharmacol，2002，80 ( 2): 116-124.
|
|
6 Das C，KumarVS，Gupm S,et al. Network of cytokines. integrinsand hormones in human trophoblast cell. J Reprod Immunol，2002,53(1-2):257-268.
|
|
7 Di SN,Castellani R,Caliandro D，et al. Antiphospholid antibodies regulate the expression of trophoblast cell adhesion molecules. Fertil Steril，2002,77(4)：805-811.
|
|
8 Hiby SE，Walker JJ，Oshaughnessy KM，et al. Combinations of maternal KIR and fetal HLA-C genes influense the risk of preeclampsia and reproductive success. J EXP Med,2004,200(8)：957-965.
|
|
9 Abrahams VM, Straszewski-Chavez SL, Guller S，et al. First trimester trophoblast cells secret Fas ligand which induce immune cell apoptosis. Mol Hum Reprod,2004,10(1) :55-63.
|
|
10 Agrawal S，Pandey MK. Prevalence of MLR blocking antibody before and after immunotherapy. Hematother Stem Cell Res,2000,9(2):257.
|
|
11 Sallinen K, Verajankorva E, Pollanen P. Expression of antigens involved in the presentation of lipid antigens and induction of clonal anergy in the female re-productive tract. Reprod Immunol，2000,46(2):91.
|
|
12 Lum H, Roebuck KA. Oxidant stress and endothelial-cell dysfunction. Am J Physiol Cell Physiol, 2001,280：719-720.
|
|
13 Tuomson NF, Thornton S，Joseph M. The effects of placental extracts from nomotensive and preeclamptic womenon, vasoconstriction and oxidative metabolism. Am J Obstet Gynecol，2000,183:206-210.
|
|
14 Amal SA, Meena K, Jing ZM,et al. Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to generate superoxide radicals in women with preeclampsia. Am J Obstet Gynecol，2004,190：252-258.
|
|
15 James M, Roberts MD，Carl AH. Oxidative stress in preeclampsia.Am J Obstet Gyneeol, 2004,190:1177-1178.
|
|
16 Belo L,Caslake M, Gaffney D,et al. Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis, 2002,162(2)：425-432.
|
|
17 Raijmakers MT, Dechend R, Poston L. Oxidative stress and preeclampsia：Rationale for antioxidant clinical trials. Hypertension，2004,44(4)：374-380.
|
|
18 Curnow KM. The LIOF mutation of angiotensinogen 16 rare in preeclampsia. Hypertension,2000,18(2)：173-178.
|
|
19 Tempfer CB, Dorman K, Deter RL, et al. An endothelial nitric oxide synthase gene polymorphism is associated with preeclampsia. Hypertens Pregnancy,2001,20(1)：107.
|